Answers are grounded in this paper and cite their sources.
The study determines the molecular mechanisms of FN3K's role in phosphorylating glycated substrates, highlighting its significance in diabetes and cancer.
Glycation, a non-enzymatic post-translational modification occurring on proteins, can be actively reversed via site-specific phosphorylation of the fructose-lysine moiety by FN3K kinase, to impact the cellular function of the target protein. A regulatory axis between FN3K and glycated protein targets has been associated with conditions like diabetes and cancer. However, the molecular basis of this relationship has not been explored so far. Here, we determined a series of crystal structures of HsFN3K in the apo-state, and in complex with different nucleotide analogs together with a sugar substrate mimic to reveal the features important for its kinase activity and substrate recognition. Additionally, the dynamics in sugar substrate binding during the kinase catalytic cycle provide important mechanistic insights into HsFN3K function. Our structural work provides the molecular basis for rational small molecule design targeting FN3K.
No takes yet. Share an insight, caveat, or question.
Garg et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: